Share Price | Modular Medical, Inc. Stock Analysis & Recommendation

Q: What does Modular Medical, Inc. do?

Overview:Modular Medical, Inc. operates within the Pharmaceuticals & Biotechnology industry and is classified as a micro-cap company.Financial Snapshot:- Most recent Net Profit: -5 Million (Quarterly Results - Dec 2024)- Market-cap: USD 42.58 Million (Micro Cap)Key Metrics:- P/E: NA (Loss Making)- Industry P/E: NA- Dividend Yield: 0.00%- Debt Equity: -0.64- Return on Equity: -177.14%- Price to Book: 4.15Contact Details:Details: No Company Details AvailableRegistrar Address: Not available.

Q: Is Modular Medical, Inc. technically bullish or bearish?

As of 22 August 2025, the technical trend for Modular Medical, Inc. has changed from bearish to mildly bearish. The weekly MACD indicates a mildly bullish stance, while the monthly MACD also shows mildly bullish. However, the Bollinger Bands and daily moving averages are both mildly bearish. The KST is mildly bullish on the weekly but bearish on the monthly, and Dow Theory presents a mixed view with mildly bearish weekly and mildly bullish monthly indicators. The OBV shows a bullish trend monthly but no trend weekly.In terms of performance, the stock has significantly underperformed compared to the S&P 500 over the longer term, with a year-to-date return of -46.72% versus the S&P 500's 12.22%, and a one-year return of -67.56% compared to 17.14% for the benchmark. Overall, the current technical stance is mildly bearish, reflecting mixed signals across various indicators.

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

260.2 k

Shareholding (Sep 2025)

FII

0.37%

Held by 9 FIIs

DII

95.81%

Held by 6 DIIs

Promoter

0.00%

How big is Modular Medical, Inc.?

22-Jun-2025

As of Jun 18, Modular Medical, Inc. has a market capitalization of 42.58 million and reported net sales of 0.00 million with a net profit of -18.18 million for the latest four quarters. Shareholder's funds were 11.54 million, and total assets amounted to 13.81 million as of Mar 24.

View full answer

What does Modular Medical, Inc. do?

22-Jun-2025

Modular Medical, Inc. is a micro-cap company in the Pharmaceuticals & Biotechnology industry, currently reporting a net profit loss of $5 million and a market cap of $42.58 million. Key financial metrics include a P/E ratio of NA, a dividend yield of 0.00%, and a return on equity of -177.14%.

View full answer

Is Modular Medical, Inc. technically bullish or bearish?

20-Sep-2025

As of August 22, 2025, Modular Medical, Inc. shows a mildly bearish technical trend with mixed signals across indicators, underperforming the S&P 500 significantly with year-to-date and one-year returns of -46.72% and -67.56%, respectively.

View full answer

Compare Modular Medical, Inc. with Similar Stocks

Check-Cap Ltd.Nortech Systems, Inc.Singular Genomics Systems, Inc.

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

Unrated Stock - No Analysis Available

Mojo Parameters

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

USD 35 Million ()

P/E

NA (Loss Making)

Industry P/E

Dividend Yield

0.00%

Debt Equity

-0.55

Return on Equity

-276.23%

Price to Book

3.97

Revenue and Profits:

Net Sales:

(Quarterly Results - Jun 2025)

Net Profit:

-7 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

-14.37%

6 Months

-40.93%

1 Year

-63.29%

2 Years

-72.35%

3 Years

-81.41%

4 Years

-95.59%

5 Years

-90.29%

Modular Medical, Inc. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

EBIT Growth (5y)

-209.27%

EBIT to Interest (avg)

-12.34

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-0.74

Sales to Capital Employed (avg)

Tax Ratio

0.01%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

32.85%

ROCE (avg)

ROE (avg)

Valuation key factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

4.46

EV to EBIT

-2.13

EV to EBITDA

-2.26

EV to Capital Employed

10.64

EV to Sales

PEG Ratio

Dividend Yield

ROCE (Latest)

-498.89%

ROE (Latest)

-177.14%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Mildly Bullish

RSI

No Signal

Bollinger Bands

Bearish

Moving Averages

Mildly Bearish (Daily)

KST

Mildly Bullish

Bearish

Dow Theory

No Trend

OBV

No Trend

Mildly Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Sep 2025

Shareholding Compare (%holding)

Majority shareholders

Domestic Funds

Held in 4 Schemes (3.82%)

Foreign Institutions

Held by 9 Foreign Institutions (0.37%)

Strategic Entities with highest holding

Highest Public shareholder

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is 0.00% vs 0.00% in Jun 2024",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is -63.41% vs -10.81% in Jun 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Jun'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-6.40",
          "val2": "-3.90",
          "chgp": "-64.10%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-6.70",
          "val2": "-4.10",
          "chgp": "-63.41%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2025 is 0.00% vs 0.00% in Mar 2024",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2025 is -7.43% vs -25.90% in Mar 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Mar'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-17.60",
          "val2": "-16.80",
          "chgp": "-4.76%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-18.80",
          "val2": "-17.50",
          "chgp": "-7.43%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY

Jun'25

Jun'24

Change(%)

Net Sales

0.00

Operating Profit (PBDIT) excl Other Income

-6.40

-3.90

-64.10%

Interest

0.00

Exceptional Items

0.00

Consolidate Net Profit

-6.70

-4.10

-63.41%

Operating Profit Margin (Excl OI)

0.00%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Jun 2025 is 0.00% vs 0.00% in Jun 2024

Consolidated Net Profit

YoY Growth in quarter ended Jun 2025 is -63.41% vs -10.81% in Jun 2024

All Quarterly Results

Annual Results Snapshot (Consolidated) - Mar'25

Mar'25

Mar'24

Change(%)

Net Sales

0.00

Operating Profit (PBDIT) excl Other Income

-17.60

-16.80

-4.76%

Interest

0.00

Exceptional Items

0.00

Consolidate Net Profit

-18.80

-17.50

-7.43%

Operating Profit Margin (Excl OI)

0.00%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Mar 2025 is 0.00% vs 0.00% in Mar 2024

Consolidated Net Profit

YoY Growth in year ended Mar 2025 is -7.43% vs -25.90% in Mar 2024

All Annual Results

Company CV

About Modular Medical, Inc.

Modular Medical, Inc.

Pharmaceuticals & Biotechnology

No Details Available.

Company Coordinates

No Company Details Available

Modular Medical, Inc.

1Day

52 Week

CASH

FII

DII

Promoter

How big is Modular Medical, Inc.?

Watch in Real-Time

What does Modular Medical, Inc. do?

Is Modular Medical, Inc. technically bullish or bearish?

Compare Modular Medical, Inc. with Similar Stocks

MarketsMojo — Loved in India, Now Global

Dashboard

Mojo Parameters

Stock DNA

Total Returns (Price + Dividend)

Risk Adjusted Returns v/s

News

Announcements

Corporate Actions

Quality key factors

Valuation key factors

Technicals key factors

Shareholding Snapshot : Sep 2025

Shareholding Compare (%holding)

Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY

Annual Results Snapshot (Consolidated) - Mar'25

About Modular Medical, Inc.

Company Coordinates